Alert detail
Proposed LCD DL40363: Anterior segment intraocular nonbiodegradable drug-eluting system — NGS
Policy ID: LCD-DL40363Specialty: OphthalmologyAdded: 6/5/2026lcd
What changed
Proposed LCD targets nonbiodegradable intraocular drug-eluting eye implants.
Who’s affected: Ophthalmology billing teams
Primary source: View the official CMS/MAC document ↗
Get the action steps and full analysis
This change affects 10 billing codes.
Subscribers get the recommended action (“what to do”), the full AI analysis, the LCD revision comparison, and related alerts across your specialty and jurisdiction.
Not ready to subscribe?
Get the free weekly reimbursement brief for Ophthalmology— the week’s changes and deadlines, delivered to your inbox. No account required.